SEARCH:
Print

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, November 7, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 

1.

Details of the   person discharging managerial responsibilities/person closely associated  

a)

Name

Paul Chaplin

2.

Reason for the   notification

a)

Position/status

 

President and   Chief Executive Officer of Bavarian Nordic A/S

b)

Initial   notification/Amendment

Initial   notification

3.

Details of the   issuer, emission allowance market participant, auction platform, auctioneer   or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the   transaction(s): section to be repeated for (i) each type of instrument; (ii)   each type of transaction; (iii) each date; and (iv) each place where   transactions have been conducted

a)

Description of   the financial instrument, type of instrument
 
 

Identification   code

Warrants


 
  DK0015998017

b)

Nature of the   transaction

Grant

c)

Price(s) and   volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

78,201

d)

Aggregated   information

-         Aggregated volume

-         Price

 

78,201

DKK 0.00

e)

Date of the   transaction

2019-11-07

f)

Place of the   transaction

Outside a trading   venue

  

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Henrik Juuel

2.

Reason for the notification

a)

Position/status

 

Executive Vice President and Chief Financial Officer   of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Warrants


 
  DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

33,950

d)

Aggregated information

-       Aggregated volume

-       Price

 

33,950

DKK 0.00

e)

Date of the transaction

2019-11-07

f)

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Henrik Birk

2.

Reason for the notification

a)

Position/status

 

Executive Vice President and Chief Operating Officer   of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Warrants


 
  DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

35,678

d)

Aggregated information

-       Aggregated volume

-       Price

 

35,678

DKK 0.00

e)

Date of the transaction

2019-11-07

f)

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/person   closely associated  

a)

Name

Tommi Kainu

2.

Reason for the notification

a)

Position/status

 

Executive Vice President and Chief Business Officer   of Bavarian Nordic A/S

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction   platform, auctioneer or auction monitor

a)

Name

Bavarian Nordic A/S

b)

LEI

2138006JCDVYIN6INP51

4.

Details of the transaction(s): section to be repeated for (i) each type   of instrument; (ii) each type of transaction; (iii) each date; and (iv) each   place where transactions have been conducted

a)

Description of the financial instrument, type of instrument
 
 

Identification code

Warrants


 
  DK0015998017

b)

Nature of the transaction

Grant

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

DKK 0.00

35,533

d)

Aggregated information

-       Aggregated volume

-       Price

 

35,533

DKK 0.00

e)

Date of the transaction

2019-11-07

f)

Place of the transaction

Outside a trading venue

 

About Bavarian Nordic
Bavarian Nordic is a fully integrated biotechnology company focused on the development of innovative therapies against infectious diseases and cancer. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates intended to unlock the power of the immune system to improve public health with a focus on high unmet medical needs. In addition to our long-standing collaboration with the U.S. government on the development and supply of medical countermeasures, including the only FDA-approved, non-replicating smallpox vaccine, our infectious disease pipeline comprises a proprietary RSV program as well as vaccine candidates for Ebola, HPV, HBV and HIV, which are developed through a strategic partnership with Janssen. Additionally, we have developed a portfolio of active cancer immunotherapies, designed to alter the disease course by eliciting a robust and broad anti-cancer immune response while maintaining a favorable benefit-risk profile. For more information visit www.bavarian-nordic.com or follow us on Twitter @bavariannordic.

Contacts
Rolf Sass Sørensen
Vice President Investor Relations (EU)
Tel: +45 61 77 47 43

Graham Morrell
Paddock Circle Advisors (US)
graham@paddockcircle.com
Tel: +1 781 686 9600

Company Announcement no. 22 / 2019

Published on November 07, 2019, 7:54 CET